{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:30:02Z","timestamp":1774020602671,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Neuroendokrine Tumoren (NET) sind eine bunte Gruppe von Neoplasien, die von neuroendokrinen Zellen im gesamten K\u00f6rper ausgehen. Die NET-Diagnose stellt aufgrund ihrer vielf\u00e4ltigen Erscheinungsformen, Morphologie und biologischen Verhaltensweisen eine besondere Herausforderung dar. Dieser Artikel bietet einen \u00dcberblick \u00fcber die wichtigsten f\u00fcr Allgemeinpathologen relevanten diagnostischen Prinzipien, und betont die Bedeutung eines multidisziplin\u00e4ren Ansatzes, der klinische, radiologische, histopathologische und immunhistochemische Daten integriert. Die Etablierung neuer Marker sowie j\u00fcngste Fortschritte in der molekularen Pathologie und die Anwendung von Klassifizierungssystemen werden er\u00f6rtert, wobei deren Einfluss auf die Prognose und therapeutische Strategien hervorgehoben wird.<\/jats:p>","DOI":"10.1007\/s00292-025-01415-z","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:10:23Z","timestamp":1739959823000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuroendokrine Neoplasien","Neuroendocrine tumors"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8812-6788","authenticated-orcid":false,"given":"Aziz","family":"Chouchane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Br\u00e4utigam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurel","family":"Perren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"4","key":"1415_CR1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/1097-0142(1971)28:4<990::AID-CNCR2820280424>3.0.CO;2-K","volume":"28","author":"J Soga","year":"1971","unstructured":"Soga\u00a0J, Tazawa\u00a0K (1971) Pathologic analysis of carcinoids. Histologic reevaluation of 62\u00a0cases. Cancer 28(4):990\u2013998. https:\/\/doi.org\/10.1002\/1097-0142(1971)28:4\u3008990::aid-cncr2820280424\u30093.0.co","journal-title":"Cancer"},{"issue":"11","key":"1415_CR2","doi-asserted-by":"publisher","first-page":"R417","DOI":"10.1530\/ERC-20-0122","volume":"27","author":"A Kasajima","year":"2020","unstructured":"Kasajima\u00a0A, Kl\u00f6ppel\u00a0G (2020) Neuroendocrine neoplasms of lung, pancreas and gut: a\u00a0morphology-based comparison. Endocr Relat Cancer 27(11):R417\u2013R432. https:\/\/doi.org\/10.1530\/ERC-20-0122","journal-title":"Endocr Relat Cancer"},{"key":"1415_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12022-022-09745-x","volume":"34","author":"M Schiavo Lena","year":"2023","unstructured":"Schiavo Lena\u00a0M, Partelli\u00a0S, Andreasi\u00a0V et\u00a0al (2023) Infiltrative growth predicts the risk of recurrence after surgery in well-differentiated non-functioning pancreatic neuroendocrine tumors. Endocr Pathol 34:142\u2013155. https:\/\/doi.org\/10.1007\/s12022-022-09745-x","journal-title":"Endocr Pathol"},{"issue":"6","key":"1415_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41379-021-00995-4","volume":"35","author":"MDRP Bagci","year":"2022","unstructured":"Orhun Cig Taskin, Bagci\u00a0MDRP et\u00a0al (2022) Infiltration pattern predicts metastasis and progression better than the T\u2011stage and grade in pancreatic neuroendocrine tumors: a\u00a0proposal for a\u00a0novel infiltration-based morphologic grading. Mod Pathol 35(6):777\u2013785. https:\/\/doi.org\/10.1038\/s41379-021-00995-4","journal-title":"Mod Pathol"},{"issue":"1","key":"1415_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","volume":"51","author":"M Tanigawa","year":"2018","unstructured":"Tanigawa\u00a0M, Nakayama\u00a0M, Taira\u00a0T et\u00a0al (2018) Insulinoma-associated protein 1 (INSM1) is a\u00a0useful marker for pancreatic neuroendocrine tumor. Med Mol Morphol 51(1):32\u201340. https:\/\/doi.org\/10.1007\/s00795-017-0167-6","journal-title":"Med Mol Morphol"},{"issue":"3","key":"1415_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000457956","volume":"105","author":"A Perren","year":"2017","unstructured":"Perren\u00a0A, Couvelard\u00a0A, Scoazec\u00a0JY et\u00a0al (2017) Antibes consensus conference participants. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology 105(3):196\u2013200. https:\/\/doi.org\/10.1159\/000457956","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1415_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1158\/2159-8290.CD-21-0669","volume":"12","author":"S Yachida","year":"2022","unstructured":"Yachida\u00a0S, Totoki\u00a0Y, No\u00eb\u00a0M et\u00a0al (2022) Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system. Cancer Discov 12(3):692\u2013711. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0669","journal-title":"Cancer Discov"},{"key":"1415_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejca.2021.04.030","volume":"152","author":"J Hadoux","year":"2021","unstructured":"Hadoux\u00a0J, Kanaan\u00a0C, Durand\u00a0A et\u00a0al (2021) Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a\u00a0focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d\u2019Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network. Eur J Cancer 152:100\u2013115. https:\/\/doi.org\/10.1016\/j.ejca.2021.04.030","journal-title":"Eur J Cancer"},{"issue":"1","key":"1415_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/ERC-21-0152","volume":"29","author":"A Venizelos","year":"2021","unstructured":"Venizelos\u00a0A, Elvebakken\u00a0H, Perren\u00a0A et\u00a0al (2021) The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 29(1):1\u201314. https:\/\/doi.org\/10.1530\/ERC-21-0152","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"1415_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/PAS.0b013e31823d07f3","volume":"36","author":"M K\u00f6rner","year":"2012","unstructured":"K\u00f6rner\u00a0M, Waser\u00a0B, Schonbrunn\u00a0A, Perren\u00a0A, Reubi\u00a0JC (2012) Somatostatin receptor subtype 2A immunohistochemistry using a\u00a0new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am J Surg Pathol 36(2):242\u2013252. https:\/\/doi.org\/10.1097\/PAS.0b013e31823d07f3","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1415_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","volume":"146","author":"I Marinoni","year":"2014","unstructured":"Marinoni\u00a0I, Kurrer\u00a0AS, Vassella\u00a0E et\u00a0al (2014) Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 146(2):453\u2013460.e5. https:\/\/doi.org\/10.1053\/j.gastro.2013.10.020","journal-title":"Gastroenterology"},{"issue":"1","key":"1415_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi\u00a0G, Mete\u00a0O, Uccella\u00a0S, Basturk\u00a0O et\u00a0al (2022) Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol 33(1):115\u2013154. https:\/\/doi.org\/10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"issue":"6","key":"1415_CR13","doi-asserted-by":"publisher","first-page":"e0179445","DOI":"10.1371\/journal.pone.0179445","volume":"12","author":"F Panzuto","year":"2017","unstructured":"Panzuto\u00a0F, Cicchese\u00a0N, Partelli\u00a0S et\u00a0al (2017) Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms. PLoS ONE 12(6):e179445. https:\/\/doi.org\/10.1371\/journal.pone.0179445","journal-title":"PLoS ONE"},{"key":"1415_CR14","doi-asserted-by":"publisher","first-page":"e13443","DOI":"10.1111\/jne.13443","volume":"7","author":"H Sorbye","year":"2024","unstructured":"Sorbye\u00a0H, Kong\u00a0G, Grozinsky-Glasberg\u00a0S, Strosberg\u00a0J (2024) PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). J\u00a0Neuroendocrinol 7:e13443. https:\/\/doi.org\/10.1111\/jne.13443","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"1415_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/01.pas.0000163363.86099.9f","volume":"29","author":"SC Abraham","year":"2005","unstructured":"Abraham\u00a0SC, Carney\u00a0JA, Ooi\u00a0A, Choti\u00a0MA, Argani\u00a0P (2005) Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a\u00a0new disorder. Am J Surg Pathol 29(7):969\u2013975. https:\/\/doi.org\/10.1097\/01.pas.0000163363.86099.9f","journal-title":"Am J Surg Pathol"},{"issue":"34","key":"1415_CR16","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.3748\/wjg.v12.i34.5440","volume":"12","author":"M Anlauf","year":"2006","unstructured":"Anlauf\u00a0M, Garbrecht\u00a0N, Henopp\u00a0T et\u00a0al (2006) Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 12(34):5440\u20135446. https:\/\/doi.org\/10.3748\/wjg.v12.i34.5440","journal-title":"World J Gastroenterol"},{"key":"1415_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11605-017-3586-8","volume":"22","author":"A Gangi","year":"2018","unstructured":"Gangi\u00a0A, Siegel\u00a0E, Barmparas\u00a0G et\u00a0al (2018) Multifocality in small bowel neuroendocrine tumors. J\u00a0Gastrointest Surg 22:303\u2013309. https:\/\/doi.org\/10.1007\/s11605-017-3586-8","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"1415_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/his.14012","volume":"76","author":"D Hoskoppal","year":"2020","unstructured":"Hoskoppal\u00a0D, Epstein\u00a0JI, Gown\u00a0AM et\u00a0al (2020) SATB2 protein expression by immunohistochemistry is a\u00a0sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Histopathology 76(4):550\u2013559. https:\/\/doi.org\/10.1111\/his.14012","journal-title":"Histopathology"},{"issue":"2","key":"1415_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(22)00750-1","volume":"24","author":"C Nesti","year":"2023","unstructured":"Nesti\u00a0C, Br\u00e4utigam\u00a0K, Benavent\u00a0M et\u00a0al (2023) Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1\u20132\u202fcm in size: a\u00a0retrospective, Europe-wide, pooled cohort study. Lancet Oncol 24(2):187\u2013194. https:\/\/doi.org\/10.1016\/S1470-2045(22)00750-1","journal-title":"Lancet Oncol"},{"issue":"6","key":"1415_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/modpathol.2012.34","volume":"25","author":"J Koo","year":"2012","unstructured":"Koo\u00a0J, Mertens\u00a0RB, Mirocha\u00a0JM, Wang\u00a0HL, Dhall\u00a0D (2012) Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin. Mod Pathol 25(6):893\u2013901. https:\/\/doi.org\/10.1038\/modpathol.2012.34","journal-title":"Mod Pathol"},{"issue":"2","key":"1415_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00428-008-0710-x","volume":"454","author":"S La Rosa","year":"2009","unstructured":"La Rosa\u00a0S, Franzi\u00a0F, Marchet\u00a0S et\u00a0al (2009) The monoclonal anti-BCL10 antibody (clone 331.1) is a\u00a0sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch 454(2):133\u2013142. https:\/\/doi.org\/10.1007\/s00428-008-0710-x","journal-title":"Virchows Arch"},{"issue":"1","key":"1415_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1677\/ERC-07-0157","volume":"15","author":"N Garbrecht","year":"2008","unstructured":"Garbrecht\u00a0N, Anlauf\u00a0M, Schmitt\u00a0A et\u00a0al (2008) Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocr Relat Cancer 15(1):229\u2013241. https:\/\/doi.org\/10.1677\/ERC-07-0157","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"1415_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1159\/000511905","volume":"111","author":"H Elvebakken","year":"2021","unstructured":"Elvebakken\u00a0H, Perren\u00a0A, Scoazec\u00a0JY et\u00a0al (2021) A\u00a0consensus-developed morphological re-evaluation of 196 high-grade gastroenteropancreatic neuroendocrine neoplasms and its clinical correlations. Neuroendocrinology 111(9):883\u2013894. https:\/\/doi.org\/10.1159\/000511905","journal-title":"Neuroendocrinology"},{"issue":"1","key":"1415_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13073-022-01018-w","volume":"14","author":"T Simon","year":"2022","unstructured":"Simon\u00a0T, Riemer\u00a0P, Jarosch\u00a0A et\u00a0al (2022) DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors. Genome Med 14(1):24. https:\/\/doi.org\/10.1186\/s13073-022-01018-w","journal-title":"Genome Med"},{"issue":"4","key":"1415_CR25","doi-asserted-by":"publisher","first-page":"e230203","DOI":"10.1530\/ERC-23-0203","volume":"31","author":"IS Cordero-Hernandez","year":"2024","unstructured":"Cordero-Hernandez\u00a0IS, Ross\u00a0AC, Dasari\u00a0A, Halperin\u00a0DM, Chasen\u00a0B, Yao\u00a0JC (2024) Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy. Endocr Relat Cancer 31(4):e230203. https:\/\/doi.org\/10.1530\/ERC-23-0203","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"1415_CR26","doi-asserted-by":"publisher","first-page":"e230051","DOI":"10.1530\/ERC-23-0051","volume":"30","author":"BF Samhouri","year":"2023","unstructured":"Samhouri\u00a0BF, Halfdanarson\u00a0TR, Koo\u00a0CW, McCarthy\u00a0C, Yi\u00a0ES, Thomas\u00a0CF, Ryu\u00a0JH (2023) DIPNECH: pragmatic approach, uncertainties, notable associations, and a\u00a0proposal for an improved definition. Endocr Relat Cancer 30(10):e230051. https:\/\/doi.org\/10.1530\/ERC-23-0051","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"1415_CR27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/PAS.0000000000000621","volume":"40","author":"D Nonaka","year":"2016","unstructured":"Nonaka\u00a0D, Papaxoinis\u00a0G, Mansoor\u00a0W (2016) Diagnostic utility of orthopedia homeobox (OTP) in pulmonary carcinoid tumors. Am J Surg Pathol 40(6):738\u2013744. https:\/\/doi.org\/10.1097\/PAS.0000000000000621","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1415_CR28","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","volume":"15","author":"MK Baine","year":"2020","unstructured":"Baine\u00a0MK, Hsieh\u00a0MS, Lai\u00a0WV et\u00a0al (2020) SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a\u00a0comprehensive immunohistochemical and histopathologic characterization. J\u00a0Thorac Oncol 15(12):1823\u20131835. https:\/\/doi.org\/10.1016\/j.jtho.2020.09.009","journal-title":"J Thorac Oncol"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-025-01415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-025-01415-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-025-01415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:33:52Z","timestamp":1740479632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-025-01415-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s00292-025-01415-z","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"19 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"A.\u00a0Chouchane gibt an, dass kein Interessenkonflikt besteht. K.\u00a0Br\u00e4utigam: A.\u00a0Finanzielle Interessen: vom Schweizerischen Nationalfonds (SNF) finanziert (PostdocMobility, P500PM_217647\/1). B.\u00a0Nichtfinanzielle Interessen: Institute of Cancer Research, Centre for Evolution and Cancer, Sutton, SM2 5NG, London, United Kingdom\/Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Pathologie, Schweizerische Gesellschaft f\u00fcr Pathologie, European Society of Pathology (ESP), PathSoc, ESSB (European Society for Spatial Biology). A.\u00a0Perren: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Schweizerischer Nationalfonds, Krebsliga Schweiz. Vortr\u00e4ge f\u00fcr ENETS, ESMO, Novartis, Ipsen. Aktien von Roche, Illumina, 4RO, Sandoz. B.\u00a0Nichtfinanzielle Interessen: Mitgliedschaften: DGP, ESP, USCAP, IAP, SwissNET, ENETS\/Stiftungsrat, NICER.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"Die Untersuchungen erfolgten unter Einhaltung der Vorgaben der Zentralen Ethikkommission der Bundes\u00e4rztekammer. F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}